The training program described in this renewal application represents a new paradigm for training academic cardiologists as cardiovascular scientists, based on the UCLA STAR (Specialty Training and Advanced Research) Program combining clinical subspecialty training with research training leading to a Ph.D. or Masters degree. This program has been in existence here at UCLA for over 13 years and has trained over 15 cardiovascular scientists and researchers. M.D. trainees will complete 2 years of subspecialty cardiology training and 3-4 years of research training that fulfills the requirements for a Ph.D. degree in Public health or one of the~basic sciences or a Masters of Clinical Investigation, including formal course work and research leading to successful thesis defense. M.D./Ph.D. trainees undergo 2 years of post-doctoral research training, including elective course work. Eight positions are requested, to provide support for the research training component only. The training faculty consists of 34 senior preceptors and 15 supporting faculty. Only senior preceptors may serve as primary research mentors, and they come from 5 groups: the UCLA Cardiovascular Research Laboratory, the UCLA Atherosclerosis Research Unit, the UCLA ACCESS Program (a multi-departmental program administering Ph.D. training in life sciences), the School of Engineering, and, for health services research, the UCLA School of Public Health and RAND Graduate School. Supporting faculty do not act as primary mentors, but play a key role in enhancing the overall research environment and fostering translational research from the basic to the clinical arena. The research programs of the faculty are supported by over 39 million dollars in direct costs annually from extramural sources. By integrating cardiology subspecialty training with the formal recruitment of Ph.D. training (or equivalent post-doctoral training for those already having a Ph.D.), the UCLA Cardiology STAR Program provides graduates with the rigorous research background essential to translate the unparalleled advances in molecular health sciences into modern molecular medicine.

Public Health Relevance

i The UCLA Cardiovascular Scientist Program is specifically designed to combine comprehensive research training leading to a Ph.D. degree or equivalent with subspecialty training in clinical cardiology for MDs. The goal of this program is to provide cardiologists with highly competitive research training, allowing them to translate advances in basic research to the clinic, or to address health service issues critical to society.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007895-14
Application #
8286988
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Carlson, Drew E
Project Start
1998-07-01
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
14
Fiscal Year
2012
Total Cost
$363,026
Indirect Cost
$30,446
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Rau, Christoph D; Wang, Jessica; Avetisyan, Rozeta et al. (2015) Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice. Circ Cardiovasc Genet 8:40-9
Young, Stephen G; Jung, Hea-Jin; Lee, John M et al. (2014) Nuclear lamins and neurobiology. Mol Cell Biol 34:2776-85
Packard, René R S; Huang, Sung-Cheng; Dahlbom, Magnus et al. (2014) Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET. J Nucl Med 55:1438-44
Lee, John M; Tu, Yiping; Tatar, Angelica et al. (2014) Reciprocal knock-in mice to investigate the functional redundancy of lamin B1 and lamin B2. Mol Biol Cell 25:1666-75
Bui, Anh L; Horwich, Tamara B; Fonarow, Gregg C (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30-41
Brockbank, Kelvin G M; Heacox, Albert E; Schenke-Layland, Katja (2011) Guidance for removal of fetal bovine serum from cryopreserved heart valve processing. Cells Tissues Organs 193:264-73
Schenke-Layland, Katja; Nsair, Ali; Van Handel, Ben et al. (2011) Recapitulation of the embryonic cardiovascular progenitor cell niche. Biomaterials 32:2748-56
Schenke-Layland, Katja; Xie, Jiansong; Magnusson, Mattias et al. (2010) Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjogren's syndrome-like exocrinopathy. Exp Eye Res 90:223-37
Schenke-Layland, Katja; Rofail, Fady; Heydarkhan, Sanaz et al. (2009) The use of three-dimensional nanostructures to instruct cells to produce extracellular matrix for regenerative medicine strategies. Biomaterials 30:4665-75
Schenke-Layland, Katja; Stock, Ulrich A; Nsair, Ali et al. (2009) Cardiomyopathy is associated with structural remodelling of heart valve extracellular matrix. Eur Heart J 30:2254-65

Showing the most recent 10 out of 23 publications